Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01296841 · ClinicalTrials.gov registry record · Phase 2
Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care
A Phase 2 study, sponsored by VA Palo Alto Health Care System.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT01296841: Completed Phase 2 study, sponsored by VA Palo Alto Health Care System.
NCT01296841 is a Phase 2 study that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 34 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01296841, a Phase 2 study, has completed, sponsored by VA Palo Alto Health Care System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
The investigators hypothesize that outpatient clinical care of Inflammatory Bowel Disease patients may be provided using a new computerized system over standard network - called Collaborative Imaging - with similar patient experience compared to a conventional clinic visit.
Primary Outcome
We used a validated Ware Specific Visit Questionnaire to assess patients' satisfaction with their clinic-visit encounter. This is a 14-item questionnaire on doctor-patient interaction including factors such as attention to complaints, technical skills, and personal manner (courtesy,and ease of appointment scheduling and is based on a five-point Likert scale (1 excellent to 5 poor). Patients completed the questionnaire at the time of the visit. The 14 item scores were individually scored and then
Interventions
- DEVICE Collaborative Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
What the finished NCT01296841 record still lists
NCT01296841 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Collaborative Imaging is the first listed.
NCT01296841 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01296841 about?
NCT01296841 is a clinical study titled "Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care". The investigators hypothesize that outpatient clinical care of Inflammatory Bowel Disease patients may be provided using a new computerized system over standard network - called Collaborative Imaging - with similar patient experience compared to a conventional clinic visit.
What is the current status of trial NCT01296841?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2009-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01296841?
The interventions under investigation include: Collaborative Imaging (DEVICE).
Who is sponsoring clinical trial NCT01296841?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01296841's enrollment target sits among peer trials
34 1539th of 2000 higher than 448 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia